Foundry Partners, LLC Horizon Therapeutics Public LTD CO Transaction History

Foundry Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$71.83 - $95.48 $2.19 Million - $2.91 Million	-30,486 Closed	0 $0
Q4 2020 Feb 04, 2021	SELL	$67.0 - $84.39 $1.68 Million - $2.11 Million	-25,048 Reduced 45.1%	30,486 $2.23 Million
Q3 2020 Oct 23, 2020	SELL	$55.23 - $79.93 $830,438 - $1.2 Million	-15,036 Reduced 21.31%	55,534 $4.31 Million
Q2 2020 Aug 03, 2020	SELL	$30.2 - $56.98 $81,721 - $154,187	-2,706 Reduced 3.69%	70,570 $3.92 Million
Q1 2020 May 08, 2020	SELL	$24.87 - $38.56 $324,279 - $502,783	-13,039 Reduced 15.11%	73,276 $2.17 Million
Q4 2019 Feb 10, 2020	SELL	$25.43 - $36.67 $842,953 - $1.22 Million	-33,148 Reduced 27.75%	86,315 $3.13 Million
Q3 2019 Oct 23, 2019	SELL	$23.0 - $27.97 $6,440 - $7,831	-280 Reduced 0.23%	119,463 $3.25 Million
Q2 2019 Jul 18, 2019	BUY	$22.81 - $28.48 $2.73 Million - $3.41 Million	119,743 New	119,743 $2.88 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Foundry Partners, LLC with notifications on news.